Sarah Ernst

Sarah Ernst

Alston & Bird

Contact

Readers' Choice Awards

Healthcare
View Bio
RSS

Latest Posts › HRSA

Share:

Health Care Week in Review: President’s Budget and ASPR Cybersecurity Guide

Below is Alston & Bird’s Health Care Week in Review, which provides a synopsis of the latest news in health care regulations, notices, and guidance; federal legislation and congressional committee action; reports, studies,...more

3/13/2023  /  Centers for Disease Control and Prevention (CDC) , Coronavirus/COVID-19 , Cybersecurity , Department of Health and Human Services (HHS) , Food and Drug Administration (FDA) , Health Care Providers , HRSA , National Institute of Health (NIH) , Popular , Public Health , Public Health Emergency

Health Care Week in Review: DEA Issues Proposed Rules on Controlled Substances Prescribing via Telemedicine

Below is Alston & Bird’s Health Care Week in Review, which provides a synopsis of the latest news in health care regulations, notices, and guidance; federal legislation and congressional committee action; reports, studies,...more

3/7/2023  /  Controlled Substances , DEA , Department of Health and Human Services (HHS) , Electronic Prescribing , Food and Drug Administration (FDA) , Health Care Providers , HRSA , National Institute of Health (NIH) , Pharmaceutical Industry , Prescription Drugs , Telehealth , Telemedicine

Health Care Week in Review: SAMHSA Releases NSDUH Survey Results, CMS Issues Medicaid Guidance

Below is Alston & Bird’s Health Care Week in Review, which provides a synopsis of the latest news in health care regulations, notices, and guidance; federal legislation and congressional committee action; reports, studies,...more

1/9/2023  /  Centers for Medicare & Medicaid Services (CMS) , Department of Health and Human Services (HHS) , Food and Drug Administration (FDA) , Health Care Providers , HRSA , Medicaid , Medical Devices , Medicare , Pharmaceutical Industry , SAMHSA

Health Care Week in Review: HHS Issued Proposed Rules and a Request for Information

Below is Alston & Bird’s Health Care Week in Review, which provides a synopsis of the latest news in health care regulations, notices, and guidance; federal legislation and congressional committee action; reports, studies,...more

12/6/2022  /  Affordable Care Act , Centers for Disease Control and Prevention (CDC) , Department of Health and Human Services (HHS) , Drug Pricing , Food and Drug Administration (FDA) , Health Care Providers , HRSA , Popular , Section 340B

Health Care Week in Review: FDA Released Its User Fee Amendments For FY 2023

Below is Alston & Bird’s Health Care Week in Review, which provides a synopsis of the latest news in health care regulations, notices, and guidance; federal legislation and congressional committee action; reports, studies,...more

10/10/2022  /  Biosimilars , Centers for Medicare & Medicaid Services (CMS) , Department of Health and Human Services (HHS) , Federal Food Drug and Cosmetic Act (FFDCA) , Food and Drug Administration (FDA) , Health Care Providers , Healthcare Facilities , HRSA , Medical Devices , National Institute of Health (NIH) , User Fees , Vaccinations

Health Care Week in Review: CMS Issues a Request for Information to Gather Public Input on Accessing Healthcare and Related...

Below is Alston & Bird’s Health Care Week in Review, which provides a synopsis of the latest news in health care regulations, notices, and guidance; federal legislation and congressional committee action; reports, studies,...more

9/13/2022  /  Centers for Disease Control and Prevention (CDC) , Centers for Medicare & Medicaid Services (CMS) , Coronavirus/COVID-19 , Department of Health and Human Services (HHS) , Food and Drug Administration (FDA) , Health Care Providers , HRSA , Prescription Drugs , Public Health Emergency , Vaccinations

Health Care Week in Review: Biden Administration Released a Final Rule on Surprise Billing

Below is Alston & Bird's Health Care Week in Review, which provides a synopsis of the latest news in health care regulations, notices, and guidance; federal legislation and congressional committee action; reports, studies,...more

8/29/2022  /  Biden Administration , Centers for Disease Control and Prevention (CDC) , Centers for Medicare & Medicaid Services (CMS) , Children's Health Insurance Program (CHIP) , Department of Health and Human Services (HHS) , Food and Drug Administration (FDA) , Health Care Providers , HRSA , Medicaid , Medicare , OIG , Pharmaceutical Industry , Surprise Medical Bills

Health Care Week in Review: President Biden’s Executive Order Securing Access to Reproductive and Health Care Services

Below is Alston & Bird's Health Care Week in Review, which provides a synopsis of the latest news in health care regulations, notices, and guidance; federal legislation and congressional committee action; reports, studies,...more

8/8/2022  /  Centers for Disease Control and Prevention (CDC) , Centers for Medicare & Medicaid Services (CMS) , Department of Health and Human Services (HHS) , Food and Drug Administration (FDA) , Health Care Providers , Hospitals , HRSA , Popular , Reproductive Healthcare Issues

Health Care Week in Review: CMS Released CY 2023 Payment Policies Under PFS Proposed Rule

Below is Alston & Bird's Health Care Week in Review, which provides a synopsis of the latest news in health care regulations, notices, and guidance; federal legislation and congressional committee action; reports, studies,...more

7/11/2022  /  Centers for Disease Control and Prevention (CDC) , Centers for Medicare & Medicaid Services (CMS) , Department of Health and Human Services (HHS) , Food and Drug Administration (FDA) , Health Care Providers , HRSA , Medicare

Health Care Week in Review: CMS Issued ESRD Proposed Rule

Below is Alston & Bird’s Health Care Week in Review, which provides a synopsis of the latest news in health care regulations, notices, and guidance; federal legislation and congressional committee action; reports, studies,...more

6/27/2022  /  Centers for Medicare & Medicaid Services (CMS) , Coronavirus/COVID-19 , Department of Health and Human Services (HHS) , Food and Drug Administration (FDA) , Health Care Providers , HRSA , National Institute of Health (NIH) , SAMHSA , Supply Chain

Alston & Bird Health Care Week in Review - May 2022 #2

Below is Alston & Bird’s Health Care Week in Review, which provides a synopsis of the latest news in health care regulations, notices, and guidance; federal legislation and congressional committee action; reports, studies,...more

5/16/2022  /  American Rescue Plan Act of 2021 , Centers for Disease Control and Prevention (CDC) , Centers for Medicare & Medicaid Services (CMS) , Coronavirus/COVID-19 , Department of Health and Human Services (HHS) , Food and Drug Administration (FDA) , Health Care Providers , Healthcare Facilities , HRSA , Medicaid , Medicare , Popular

Alston & Bird Health Care Week in Review - April 2022 #3

Below is Alston & Bird’s Health Care Week in Review, which provides a synopsis of the latest news in health care regulations, notices, and guidance; federal legislation and congressional committee action; reports, studies,...more

4/18/2022  /  Abbreviated New Drug Application (ANDA) , Advisory Board , CBO Report , Centers for Disease Control and Prevention (CDC) , Centers for Medicare & Medicaid Services (CMS) , Department of Health and Human Services (HHS) , Final Guidance , Food and Drug Administration (FDA) , Health Care Providers , HRSA , Information Reports , Medical Devices , National Institute of Health (NIH) , Popular , Prescription Drugs , Proposed Rules , Public Meetings , Public Policy
12 Results
 / 
View per page
Page: of 1

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
Sign up Log in
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide